Journal
MOLECULAR BRAIN
Volume 8, Issue -, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/s13041-015-0166-2
Keywords
CaMKII; Alzheimer's disease; Post-mortem brain; Autophosphorylation; Memory; Tau
Categories
Funding
- Medical Research Council
- Medical Research Council [G0800393, 1523477] Funding Source: researchfish
- MRC [G0800393] Funding Source: UKRI
Ask authors/readers for more resources
CaMKII is a remarkably complex protein kinase, known to have a fundamental role in synaptic plasticity and memory formation. Further, CaMKII has also been suggested to be a tau kinase. CaMKII dysregulation may therefore be a modulator of toxicity in Alzheimer's disease, a dementia characterised by aberrant calcium signalling, synapse and neuronal loss, and impaired memory. Here, we first examine the evidence for CaMKII dysregulation in Alzheimer's patients and draw parallels to findings in disease models which recapitulate key aspects of the disease. We then put forward the hypothesis that these changes critically contribute to neurodegeneration and memory impairment in Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available